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Table 1. Causes of adrenal insufficiency according to underlying pathogenesis. Most frequent causes of primary adrenal insufficiency are 
autoimmune adrenalitis and congenital adrenal hyperplasia; secondary adrenal insufficiency is most frequently the result of hypothalamic-pituitary 
tumours and their treatment. 
 
Cause Primary adrenal insufficiency Secondary adrenal insufficiency 
Autoimmune • Can occur in isolation or as part of autoimmune 
polyglandular syndromes (APS) 
• Isolated Addison’s disease (30-40% of patients with 
autoimmune adrenalitis) 
• APS type 1 (5-10%; also termed APECED OMIM 240300): 
caused by AIRE gene mutations. Adrenal insufficiency in 
combination with other endocrine (hypoparathyroidism (76-
93%), premature ovarian failure (17-50%), type 1 diabetes 
mellitus (2-12%)) and non-endocrine autoimmune disease 
(mucocutaneous candidiasis (73-100%), alopecia (29-37%), 
vitiligo (8-15%), coeliac disease (15-22%), pernicious 
anaemia (13-15%), autoimmune hepatitis (12-20%), Sjogren 
Syndrome (12%) and ectodermal dystrophy (dental enamel 
hypoplasia) (77-82%)) 
• APS type 2 (60%): adrenal insufficiency in combination 
with other endocrine autoimmune disease (hypo- or 
hyperthyroidism (60%), premature ovarian failure (7-21%), 
• Lymphocytic hypophysitis – rare, may occur in relation to 
pregnancy. Can present as panhypopituitarism or isolated 
ACTH deficiency, the latter sometimes in combination 
with primary autoimmune-mediated hypothyroidism) 
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type 1 diabetes mellitus (1-15%), pernicious anaemia (5-
12%), vitiligo (6-14%), coeliac disease (1-4%), alopecia (2-
6%))  
Compression / 
replacement of 
normal tissue 
Bilateral adrenal metastasis (mostly originating from solid organ 
tumours such as lung, breast, colon cancer) 
 
Pituitary macroadenomas (pituitary carcinoma very rare); 
craniopharyngioma; meningioma; ependymoma; intra- and 
suprasellar metastases (mostly lung, breast, colon cancer) 
Infection  Tuberculosis; HIV; CMV; fungal infections Tuberculosis; histoplasmosis; actinomycosis 
Hemorrhage / 
necrosis  
/thrombosis 
Thrombocytopenia; Waterhouse-Friderichsen syndrome; trauma; 
lupus erythematosus; antiphospholipid syndrome, panarteritis 
nodosa; treatment with anticoagulants; treatment with tyrosine 
kinase inhibitors 
Pituitary apoplexy (mostly in the setting of a pituitary 
macroadenoma); Sheehan syndrome due to transient 
hypocirculation and subsequent necrosis of the pituitary        
(e.g. due to significant blood loss) 
Infiltration Sarcoidosis, amyloidosis, haemochromatosis, histiocytosis, 
lymphoma  
Wegener’s granulomatosis, sarcoidosis, amyloidosis, 
haemochromatosis, lymphoma 
Surgery/ 
Trauma 
Bilateral adrenalectomy  Treatment of hypothalamic-pituitary tumours by surgery 
and/or radiation; traumatic brain injury 
Monogenic 
causes of 
adrenal 
insufficiency 
Congenital adrenal hyperplasia (CAH) variants:  
- 21-hydroxylase deficiency (21OHD) (OMIM #201910) (most 
common cause of disease; >95% of CAH cases) 
- 11β-hydroxylase deficiency (11OHD) (OMIM #610613) 
- P450 oxidoreductase deficiency (PORD) (OMIM #613571) 
- 3β-hydroxysteroid dehydrogenase  type 2 (3β-HSD2 ) 
deficiency (OMIM #613890); 
- 17α- hydroxylase deficiency (17OHD) (OMIM #202110) 
 
X-linked adrenoleukodystrophy (ALD) or 
Combined pituitary hormone deficiency (CPHD) variants: 
CPHD2 (OMIM #262600) 
CPHD3 (OMIM #221750) 
CPHD4 (OMIM #262700) 
CPHD5 (OMIM #182230) 
CPHD6 (OMIM #613986) 
 
Isolated ACTH deficiency due to mutations in TBX19 (OMIM 
#201400); 
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adrenomyeloneuropathy (AMN) (OMIM #300100) 
 
APS type 1 (=APECED) (OMIM #240300) 
 
For very rare inborn causes of primary adrenal insufficiency 
including congenital lipoid adrenal hyperplasia, congenital 
adrenal hypoplasia and familial glucocorticoid deficiency see 
Supplemental Table 1.  
 
For more details on the above and even rarer inborn causes of 
secondary adrenal insufficiency see Supplemental Table 2. 
Drugs 
interfering 
with adrenal 
function 
Increased metabolism of glucocorticoids: concomitant use reduces corticosteroid levels  
• Inducers of CYP3A4 (resulting in increased inactivation of cortisol by 6β-hydroxylation) - mitotane, phenytoin, 
rifampicin, troglitazone, phenobarbital 
 
Impaired glucocorticoid action: peripheral glucocorticoid insensitivity 
• Glucocorticoid receptor antagonist - mifepristone (RU486) 
• Suppression of glucocorticoid-induced gene transcription – chlorpromazine, imipramine 
 
Suppression of hypothalamic-pituitary-adrenal axis: 
• Down-regulation of endogenous ACTH release:  chronic exogenous glucocorticoid administration (including topical, 
inhaled, oral, intra-articular or parenteral administration), megestrol acetate, medroxyprogesterone acetate, cyproterone 
acetate, opiates 
 
Inhibition of steroidogenic enzymes involved in cortisol production 
• Inhibition of mitochondrial (type 1) cytochrome P450 enzymes (CYP11A1, CYP11B1/2): ketoconazole, fluconazole, 
itraconazole, etomidate, metyrapone, aminoglutethimide 
• Inhibition of 3β-HSD2: trilostane 
 
Adrenal haemorrhage 
• Anticoagulants: heparin, warfarin 
 
Autoimmune hypohysitis:   
• Anti-CTLA4 antibody: ipilimumab 
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Table 2: Measures for prevention of adrenal crisis 
 
Action point Intervention  
Identify and define the 
problem 
• Steroid emergency card (check that available and up to date) 
• Medical alert bracelet or necklace: “Adrenal insufficiency – needs steroids!” 
Educate patient (and 
partner/parents) 
 
Sick day rule 1: Need to double the routine oal glucocorticoid dose when the patient experiences fever, 
illness requiring bed rest or when requiring antibiotics for an infection 
 
Sick day rule 2: Need to inject  a glucocorticoid preparation intra-muscularly or intravenously in case of 
severe illness, trauma, persistent vomiting, when fasting for a procedure (colonoscopy!) or during surgical 
intervention. 
 
Special attention to: 
• Explaining the rationale for dose adjustment in stress / sickness  
• Discussing the situations requiring dose adjustment 
• Discussing symptoms and signs of emergency adrenal crisis 
• Teaching parenteral self-administration of glucocorticoid preparation 
• Enforce the need to go to hospital after emergency injection 
 
Provide patient with • Sufficient supply of hydrocortisone and fludrocortisone (accounting for possible sick days) 
• Hydrocortisone emergency injection kit prescription (vials of 100 mg hydrocortisone sodium such as 
Solu-Cortef, syringes, needles; alternatively also hydrocortisone or prednisolone suppositories)  
• Leaflet with information on adrenal crisis and hospitalization to be shown to health care staff, clearly 
advise regarding the need to inject 100 mg hydrocortisone immediately i.v. or i.m., followed by 
continuous infusion of 200 mg/24 hrs 
• Emergency phone number of endocrine specialist team 
 
Follow up Re-enforce education and confirm understanding during each follow up visit (at least annually in a patient 
without specific problems or recent crises, otherwise more frequently) 
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